BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15759260)

  • 1. Retrospective family study of childhood medulloblastoma.
    Ng D; Stavrou T; Liu L; Taylor MD; Gold B; Dean M; Kelley MJ; Dubovsky EC; Vezina G; Nicholson HS; Byrne J; Rutka JT; Hogg D; Reaman GH; Goldstein AM
    Am J Med Genet A; 2005 May; 134(4):399-403. PubMed ID: 15759260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
    Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
    Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
    Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
    J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
    Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
    Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
    Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
    Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
    Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
    Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant].
    Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K
    Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome.
    Durmaz CD; Evans G; Smith MJ; Ertop P; Akay BN; Tuncalı T
    Cytogenet Genome Res; 2018; 154(2):57-61. PubMed ID: 29544218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First evidence of genotype-phenotype correlations in Gorlin syndrome.
    Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT
    J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional up-regulation of Gadd45a in Patched-associated medulloblastoma.
    Kappler R; Hess I; Schlegel J; Hahn H
    Int J Oncol; 2004 Jul; 25(1):113-20. PubMed ID: 15201996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two new patients with Curry-Jones syndrome with trichoblastoma and medulloblastoma suggest an etiologic role of the sonic hedgehog-patched-GLI pathway.
    Grange DK; Clericuzio CL; Bayliss SJ; Berk DR; Heideman RL; Higginson JK; Julian S; Lind A
    Am J Med Genet A; 2008 Oct; 146A(20):2589-97. PubMed ID: 18798318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
    Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
    Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLI3 is not mutated commonly in sporadic medulloblastomas.
    Erez A; Ilan T; Amariglio N; Muler I; Brok-Simoni F; Rechavi G; Izraeli S
    Cancer; 2002 Jul; 95(1):28-31. PubMed ID: 12115313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
    Brugières L; Pierron G; Chompret A; Paillerets BB; Di Rocco F; Varlet P; Pierre-Kahn A; Caron O; Grill J; Delattre O
    J Med Genet; 2010 Feb; 47(2):142-4. PubMed ID: 19833601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
    Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
    Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PTCH1 mutations in Japanese Nevoid basal cell carcinoma syndrome patients: two familial and three sporadic cases including the first Japanese patient with medulloblastoma.
    Fujii M; Noguchi K; Urade M; Muraki Y; Moridera K; Kishimoto H; Hashimoto-Tamaoki T; Nakano Y
    J Hum Genet; 2011 Apr; 56(4):277-83. PubMed ID: 21368767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid diagnosis of medulloblastoma molecular subgroups.
    Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
    Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
    Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
    Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.